Maskot/DigitalVision via Getty Images Investment Overview Moderna, Inc. (NASDAQ:MRNA) held an investor event today to review its vaccines program and provide key business updates. Before we dive into that, let’s quickly review recent performance. The company announced its Q4 and full year 2023 earnings and business updates on February 22nd. Moderna described 2023 as a…
RiverNorthPhotography/iStock Unreleased via Getty Images Back in March, I placed a “Strong Buy” rating on J.Jill (NYSE:JILL), saying the stock was way too cheap to ignore and that it may be the best story in retail. The stock is down about -8% since then. With the company recently reporting earnings, let’s catch up on the…
Mike Hansen DISCLAIMER: This note is intended for US recipients only and, in particular, is not directed at, nor intended to be relied upon by any UK recipients. Any information or analysis in this note is not an offer to sell or the solicitation of an offer to buy any securities. Nothing in this note…